IGBA Statement on trade barriers and their impact on healthcare systems and patients’ health (March 2025)
The International Generic and Biosimilar medicines Association (IGBA) remains committed to its vision of working to improve patient access to safe, effective, cost-effective, and quality-assured generic and biosimilar medicines.
